Zimmer Biomet signed a definitive agreement to acquire OrthoGrid Systems, a privately-held medical technology company focused on artificial intelligence (AI)-driven surgical guidance systems for total hip replacement. The acquisition includes OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform Hip AI, as well as two additional FDA-cleared orthopedic applications and over 40 patents.
The transaction is slated to close by the end of 4Q24.
OrthoGrid’s Hip AI system provides real-time image analysis, automated measurements of leg length and offset, and guidance on optimal cup placement while maintaining a small OR footprint. Surgeons can tailor Hip AI to align with their specific technique and workflow.
OrthoGrid Systems introduced the OrthoGrid Hip Artificial Intelligence application in 2022. Since launch, the app has contributed to an 185% increase in OrthoGrid total hip replacement case volume. To date, it has supported over 30,000 surgeries, contributing to the 100,000 procedures completed using OrthoGrid’s range of previously analog and now digital hip products.
“OrthoGrid’s AI systems address the rapidly growing market demand for fluoroscopy-based surgical guidance solutions while strengthening our portfolio of hip offerings that drive intraoperative efficiencies and improve the quality of life for patients,” said Jim Lancaster, President, Recon and Global Headquarters Executive Director at Zimmer Biomet.
Zimmer Biomet signed a definitive agreement to acquire OrthoGrid Systems, a privately-held medical technology company focused on artificial intelligence (AI)-driven surgical guidance systems for total hip replacement. The acquisition includes OrthoGrid's AI-powered, fluoroscopy-based surgical assistance platform Hip AI, as well as two additional...
Zimmer Biomet signed a definitive agreement to acquire OrthoGrid Systems, a privately-held medical technology company focused on artificial intelligence (AI)-driven surgical guidance systems for total hip replacement. The acquisition includes OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform Hip AI, as well as two additional FDA-cleared orthopedic applications and over 40 patents.
The transaction is slated to close by the end of 4Q24.
OrthoGrid’s Hip AI system provides real-time image analysis, automated measurements of leg length and offset, and guidance on optimal cup placement while maintaining a small OR footprint. Surgeons can tailor Hip AI to align with their specific technique and workflow.
OrthoGrid Systems introduced the OrthoGrid Hip Artificial Intelligence application in 2022. Since launch, the app has contributed to an 185% increase in OrthoGrid total hip replacement case volume. To date, it has supported over 30,000 surgeries, contributing to the 100,000 procedures completed using OrthoGrid’s range of previously analog and now digital hip products.
“OrthoGrid’s AI systems address the rapidly growing market demand for fluoroscopy-based surgical guidance solutions while strengthening our portfolio of hip offerings that drive intraoperative efficiencies and improve the quality of life for patients,” said Jim Lancaster, President, Recon and Global Headquarters Executive Director at Zimmer Biomet.
Copy to clipboard 
